The elevated secretion of S100A4 from bone-metastatic mtMDA cells (Fig. 2) and the stimulation of osteoclastogenesis by S100A4 (Fig. 4) led us to next investigate the in vivo relevance of S100A4 in the bone destruction induced by bone-metastasized cancers. This evidence concerns the gene S100A4 and cancer.